AusÃn, P.; Navarrete-Rouco, M.E.; Carazo, L.; Sanchez-Trincado, J.L.; Luzon, E.; Nuevo, J.; SantÃn, M.; Sánchez, J.; Padilla-Galo, A.
Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study. J. Clin. Med. 2025, 14, 3011.
https://doi.org/10.3390/jcm14093011
AMA Style
AusÃn P, Navarrete-Rouco ME, Carazo L, Sanchez-Trincado JL, Luzon E, Nuevo J, SantÃn M, Sánchez J, Padilla-Galo A.
Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study. Journal of Clinical Medicine. 2025; 14(9):3011.
https://doi.org/10.3390/jcm14093011
Chicago/Turabian Style
AusÃn, Pilar, MarÃa Eugenia Navarrete-Rouco, Luis Carazo, Jose Luis Sanchez-Trincado, Elisa Luzon, Javier Nuevo, Mónica SantÃn, Jesús Sánchez, and Alicia Padilla-Galo.
2025. "Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study" Journal of Clinical Medicine 14, no. 9: 3011.
https://doi.org/10.3390/jcm14093011
APA Style
AusÃn, P., Navarrete-Rouco, M. E., Carazo, L., Sanchez-Trincado, J. L., Luzon, E., Nuevo, J., SantÃn, M., Sánchez, J., & Padilla-Galo, A.
(2025). Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study. Journal of Clinical Medicine, 14(9), 3011.
https://doi.org/10.3390/jcm14093011
